Please ensure Javascript is enabled for purposes of website accessibility

Ask a Fool: Is Gilead Sciences, Inc. a Sell?

By Dave Williamson – Jan 11, 2014 at 8:05AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Can Gilead's big run in 2013 be replicated in 2014?

In this video, as part of The Motley Fool's "Ask a Fool" series, health-care analyst David Williamson takes a question from a Fool reader, who asks:

Gilead Sciences (GILD 2.36%) seems to be on a down trend. Is there any specific reason, or should I just hold firm?

 

David Williamson owns shares of AbbVie. Follow David on Twitter: @MotleyDavid.

The Motley Fool recommends Gilead Sciences. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.